Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celsus Labs is a specialized biotechnology company focused on the isolation, purification, and characterization of complex carbohydrates, specifically glycosaminoglycans (GAGs). Based in Cincinnati, Ohio, the company provides high-purity heparin, heparan sulfate, dermatan sulfate, and chondroitin sulfate to the global research and pharmaceutical communities. Their expertise lies in the fractionation and chemical modification of these molecules, supporting drug discovery and development in areas such as anticoagulation, inflammation, and oncology. Celsus Labs serves as a critical supplier for academic researchers and industrial partners requiring well-defined carbohydrate standards and bulk materials for therapeutic applications. The company also offers custom purification and analytical services to meet specific client requirements in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celsus Labs.